Using the AKAP11 predicted diagnoses, we find that those most vulnerable to
SCZ are males under 30 and those most vulnerable to BPD are females
between 50 and 55, as can be seen from the largest frequencies in Fig. \ref{628883} and \ref{230418}.
We perform an F-test and Shapiro–Wilk Test for both diseases to ensure
appropriate use of TOST. Table \ref{stats-results} summarizes the p values
obtained from these tests. Since both data sets pass the Shapiro–Wilk
Test, we reject the null hypothesis that the Canadian and AKAP11 data sets for SCZ and BPD are not normally distributed, which makes them
both a suitable subject for t testing. The bipolar data set does
not pass the F-test, so we accept the null hypothesis that it has an
unequal variance between the Canadian population and AKAP11 predicted results. By extension, the bipolar data set requires an
unequal variance t test and the schizophrenia data set requires a
standard student’s t test.